By Mike Montemarano, Associate Editor 03.31.22
Within its FY2023 budget request, the U.S. Food and Drug Administration (FDA) requested that Congress pass legislation to amend the Dietary Supplement Health and Education Act (DSHEA) to establish a mandatory product listing program and clarify its authority to facilitate enforcement. The idea of a mandatory product listing has been floated before, and opinions among trade associations have been mixed.
In this year’s budget request, recently-appointed FDA Commissioner Robert Califf, MD, requested a budget of $8.4 billion, representing a 34% ($2.1 billion) increase from last year’s budget. While FDA identified many spending priorities relevant to the dietary supplements world, industry leadership weighed in mostly on the mandatory product listing portion of the request, which included both appropriations and legislative change.
In the request, “Justification of Estimates for Appropriations Committees,” the agency said that it seeks &l
In this year’s budget request, recently-appointed FDA Commissioner Robert Califf, MD, requested a budget of $8.4 billion, representing a 34% ($2.1 billion) increase from last year’s budget. While FDA identified many spending priorities relevant to the dietary supplements world, industry leadership weighed in mostly on the mandatory product listing portion of the request, which included both appropriations and legislative change.
In the request, “Justification of Estimates for Appropriations Committees,” the agency said that it seeks &l
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
